Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Illerhaus

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Blood|October 27, 2007
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group reportNancy D Doolittle, Lauren E Abrey, Tamara N Shenkier, et al.
Blood|July 2, 2008
CNS Hodgkin lymphomaElizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Hematological Oncology|August 17, 2019
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysisAndreas M Schmitt, Amanda K Herbrand, Christopher P Fox, et al.
BMC Cancer|February 17, 2017
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patientsBerta Laquente, Jose Lopez-Martin, Donald Richards, et al.
Neurology|May 21, 2013
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphomaNancy D Doolittle, Agnieszka Korfel, Meredith A Lubow, et al.
British Journal of Haematology|January 31, 2020
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practiceElisabeth Schorb, Christopher P Fox, Benjamin Kasenda, et al.
Hemasphere|July 26, 2023
Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 PatientsHannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, et al.
Hemasphere|June 5, 2024
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndreas J M Ferreri, Gerald Illerhaus, Jeanette K Doorduijn, et al.
Neuropathology and Applied Neurobiology|March 7, 2023
Patient-derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphomaLisa Kristina Isbell, Cordula Tschuch, Soroush Doostkam, et al.
Cancers|December 24, 2021
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study ProtocolAnna M Mc Laughlin, Eduard Schmulenson, Olga Teplytska, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Blood|October 27, 2007
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group reportNancy D Doolittle, Lauren E Abrey, Tamara N Shenkier, et al.
Blood|July 2, 2008
CNS Hodgkin lymphomaElizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Hematological Oncology|August 17, 2019
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysisAndreas M Schmitt, Amanda K Herbrand, Christopher P Fox, et al.
BMC Cancer|February 17, 2017
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patientsBerta Laquente, Jose Lopez-Martin, Donald Richards, et al.
Neurology|May 21, 2013
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphomaNancy D Doolittle, Agnieszka Korfel, Meredith A Lubow, et al.
British Journal of Haematology|January 31, 2020
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practiceElisabeth Schorb, Christopher P Fox, Benjamin Kasenda, et al.
Hemasphere|July 26, 2023
Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 PatientsHannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, et al.
Hemasphere|June 5, 2024
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndreas J M Ferreri, Gerald Illerhaus, Jeanette K Doorduijn, et al.
Neuropathology and Applied Neurobiology|March 7, 2023
Patient-derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphomaLisa Kristina Isbell, Cordula Tschuch, Soroush Doostkam, et al.
Cancers|December 24, 2021
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study ProtocolAnna M Mc Laughlin, Eduard Schmulenson, Olga Teplytska, et al.
Pageof 8